Oxford

Clinical Genomics & Molecular Diagnostics

10:00 – 17:00
Monday 19th November 2018
Oxford Spires Hotel, Abingdon Road, Oxford, OX1 4PS

The ‘Clinical Genomics & Molecular Diagnostics Meeting’ is a medical education meeting in lymphoid malignancies focusing on Chronic Lymphocytic Leukaemia (CLL) and Follicular Lymphoma (FL). The meeting will bring together a notable faculty of oncology experts who will preview the latest advances in research, consider the likely impact on the clinic of tomorrow, and discuss and debate the pertinent issues which are affecting the professional community. The meeting offers you and the audience the opportunity to discuss with peers and experts the latest scientific data likely to shape the treatment paradigms in these respective fields.

 


Chair

Dr Anna SchuhDr Anna Schuh
Associate Professor,
Director of Molecular Diagnostics,
Honorary Consultant Haematologist,
University of Oxford, UK

Programme
The full programme can be viewed HERE


Who should attend?
This meeting is ideal for:

  • Nurses
  • Consultants
  • GPs
  • Pharmacists
  • Researchers and
  • Scientists

and any healthcare professionals who have an interest in the future shape and direction of FL & CLL research and treatment.


CPD
Continuing Professional Development (CPD) accreditation for this meeting has been applied to the Royal College of Physicians and more information will be available shortly.


When & Where
Monday 19th November 2018, 09:30 – 17:00
Oxford Spires Hotel,
Abingdon Rd,
Oxford. OX1 4PS.
Map here


Costs
The meeting costs are underwritten by Gilead Sciences Ltd. and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity.

ONC/UK/18-02/NMAR/1080g(1)
Date of preparation: August 2018

This activity is intended for medical Haematology/Oncology specialists, Pathologists, Pharmacists, Nurses and other healthcare professionals involved in the management of CLL/FL. This is a medical education meeting organised and funded by Gilead Sciences Ltd., a science-based pharmaceutical company. This meeting is a medical education programme designed for healthcare professionals based in the UK and the Republic of Ireland only.